ARTICLE | Company News
Eli Lilly neurology, musculoskeletal, cancer news
July 22, 2013 7:00 AM UTC
Eli Lilly said it is suspending base pay increases for most employees, including executives, in 2014 to curb the impact of the expiration of U.S. patents for neurology drug Cymbalta duloxetine and os...